活动简介
ConferenceSeries Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “9thAnnual Pharmaceutical Analysis Congress” (Pharma Analysis 2017) scheduled to be held during October 02-03, 2017 at Vienna, Austria. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharma Analysis and Clinical Trials.
ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
2017 Highlights:
-
300+ Participation (70 Industry: 30 Academia)
-
5+ Keynote Speakers
-
50+ Plenary Speakers
-
20+ Exhibitors
-
14 Innovative Educational Sessions
-
5+ Workshops
Theme: Innovations in Pharmaceutical Analysis and Quality
The global pharmaceutical excipients market is projected to reach USD 8.1 Billion in 2021 at a CAGR of 6.1% in the forecast period 2016 to 2021. The rising demand for new drug delivery systems, greater understanding of the functional benefits of excipients, growing pharmaceutical industry, and patent expiries of several blockbuster drugs are positively impacting the overall growth of the market.The global particle size analysis market over the forecast period of 2017 to 2021. The market is expected to reach USD 256.1 Million by 2021, at CAGR of 4.7% from 2017 to 2021. Increasing nanotechnology research, presence of stringent regulatory guidelines to ensure compliance with GMP guidelines, and growing efforts by players to expand their geographic presence are driving the growth of the particle size analysis market during the forecast period.Analysis software market is expected to reach USD 3,135.3 Million by 2020 from USD 2,143.7 Million in 2017, at a CAGR of 7.9% from 2017 to 2020.
The global single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion in 2017 at a CAGR of 18.2%. The global market is broadly classified into product, cell type, technique, application, end-users, and regions.Many of these materials are not compatible with body tissues and fluids and can cause complications such as infections and blood clots. According to the Centers for Disease Control and Prevention (CDC), around 2,000,000 patients contract hospital-acquired infections (HAIs) every year in the U.S., resulting in 100,000 deaths; HAIs cost the U.S. healthcare system an estimated USD 45 billion annually.
Scope and Importance:
Pharmaceutical analysis services to support development programs (R&D), regulatory submissions, GMP manufacturing and post-marketing requirements. Pharmaceutical analysis plays an important role in both the development process and GMP manufacturing. Concerns about drug safety, costly development programs, complex manufacturing, market demands for evidence-based data and increased regulatory requirements are all issues that can be addressed through a better understanding of your drug substance, drug product or manufacturing process which, in turn, can only be achieved through experienced analytical studies and robust analytical data.
征稿信息
征稿范围
Track 1:Pharmaceutical Development and Technology
Track 1-1Nanotechnology for enhancing bioavailability
Track 1-2Biopharmaceutics and Pharmacokinetics
Track 1-3Optimization techniques
Track 1-4Methodological advancements in pharmaceutical industries
Track 1-5Novel drug target approaches
Track 1-6Recent advances in medical devices
Track 2:Advances and applications in HPLC Techniques
Track 2-1 Hyphenated HPLC methods
Track 2-2 Adsorption chromatography
Track 2-3Chip based separations
Track 2-4Ion exchange chromatography
Track 2-5Separation techniques in chemistry
Track 2-6Novel techniques in chromatography
Track 3:Regulatory Affairs
Track 3-1Career development in regulatory affairs
Track 3-2Regulatory strategies and developments
Track 3-3Regulatory communications and submissions
Track 3-4Regulatory challenges for medical devices
Track 3-5Regulatory requirements for pharmaceuticals
Track 3-6Biologics and Biosimilars
Track 4:Quality Control, Quality Assurance and Regulatory Filings
Track 4-1Quality control in pharmaceutical labs
Track 4-2Current regulations and quality Standards
Track 4-3 The role of quality impact assessment and effectiveness checks
Track 4-4Contract and sterile/aseptic manufacturing
Track 4-5Storage, distribution, and transportation
Track 4-6Formulation development
Track 4-7Industrial pharmacy
Track 5:Pharmaceutical Methods and Innovations in Pharma Engineering
Track 5-1Regulatory Requirements for Pharmaceuticals
Track 5-2Medico Marketing & Digital Pharma
Track 5-3Generics and Biologics
Track 5-4Pharma and Biotech Financial Outlook
Track 5-5R&D Advancement and Development
Track 5-6Clinical Pharmacy and Therapeutics
Track 5-7Pharmaceutical Sciences
Track 6:Pharmaceutical Nanotechnology
Track 6-1Pre-formulation and formulation aspects
Track 6-2Pharmacokinetics and pharmacodynamics in drugs
Track 6-3Drug targeting and design
Track 6-4Nanotechnology in drug delivery
Track 6-5Smart Drug Delivery Systems
Track 6-6Biomaterials in Drug Delivery
Track 6-7Vaccine drug delivery systems
Track 6-8Medical Devices for Drug Delivery
Track 6-9Peptides and protein drug delivery
Track 7:Chromatography
Track 7-1Adsorption chromatography
Track 7-2Advancement and application in chromatography
Track 7-3Special techniques in chromatography
Track 7-4High performance liquid chromatography
Track 7-5Gas chromatography
Track 7-6Affinity chromatography
Track 7-7Separation techniques in chemistry
Track 7-8Ion exchange chromatography
Track 7-9Partition chromatography
Track 7-10Novel techniques in chromatography
Track 8:Drug Formulation & Drug Design Pre-Formulation
Track 8-1Novel drug delivery system
Track 8-2Computer aided drug designing (CADD)
Track 8-3Drug targeting and rational drug design
Track 8-4Pharmacokinetics and pharmacodynamics in drugs
Track 8-5Analytical method development and validation
Track 8-6Drug product manufacturing
Track 8-7Shelf life and stability studies
Track 8-8Role of API in research and development
Track 8-9Drug evolution process of IND, NDA & ANDA
Track 8-10Bio markers in drug designing
Track 9:Bioavailability and Bioequivalence
Track 9-1Clinical trials
Track 9-2Contract research organizations
Track 9-3Challenges in drug design and drug development
Track 9-4Bioavailability and bioequivalence studies
Track 9-5Nutrient bioavailability
Track 9-6Advances in BA and BE
Track 10:Separation Processes in Chemical Manufacturing Industries.
Track 10-1Membrane technology in separation processes
Track 10-2Novel separation techniques in chemistry
Track 10-3Emerging separation technologies
Track 10-4Advancements in sample preparation techniques
Track 10-5Chromatography as a separation technique
Track 10-6Hyphenated techniques
Track 10-7Applications of separation techniques
Track 11:Spectroscopy in Pharmaceutical Analysis
Track 11-1Applications and innovations in mass spectrometry
Track 11-2Spectrometry in proteomics
Track 11-3Recent advances and development in spectrometry
Track 11-4Mass spectrometry imaging
Track 11-5Fundamentals of spectrometry
Track 11-6Ionization techniques
Track 11-7Spectrometry configurations and sample preparation techniques
Track 11-8Chromatography and high performance liquid chromatography (HPLC)
Track 12:Design and Analysis in Chemical Research
Track 12-1Pharmacological research chemicals in the context of drug law avoidance
Track 12-2Processes of discovering and devising new pharmacotherapy
Track 12-3Design and analysis in chemical research and development
Track 12-4Chemists in research and development laboratories
Track 12-5Relationship between regression coefficients in LVR and MLR
Track 13:Aqueous and Non-Aqueous Titrimetric Method
Track 13-1Physical and chemical characteristic of the drug molecule
Track 13-2Lowry and bronsted’s theory
Track 13-3Analysis of liquid and solid dosage forms
Track 13-4Effects of temperature on assay
Track 13-5Protogenic and Amphiprotic solvents
Track 14:Errors in Pharmaceutical Analysis
Track 14-1Procedure for sampling techniques
Track 14-2Validation of pharmaceutical analysis
Track 14-3Determinate or systematic error
Track 14-4Indeterminate or random error
Track 14-5Basic calculation in pharmaceutical analysis
Track 15:Determine The Accuracy and Precision of Drug
Track 15-1Parameters of validation
Track 15-2Purity and management of pharma analysis
Track 15-3Pharmaceutical chemical management
Track 15-4Linearity and Range
Track 16:Modern Pharmaceutical Analysis
Track 16-1Documentation of pharma industry
Track 16-2Regulation of the quality of analytical methods
Track 16-3Biological respond and chemical purity
Track 16-4Thermo analytical analysis
Track 16-5High performance liquid chromatography
Track 17:Limit Test for Quantitative Analysis
Track 17-1Stabilty of drug dosade form
Track 17-2Tests for arsenic
Track 17-3Tests for chloride
Track 17-4Quantitative determinations
Track 18:Degradation and Impurity Analysis of Different Dosage Forms
Track 18-1Weak bases in mixed aqueous and non-aqueous media
Track 18-2Qualitative and quantitative analysis
Track 18-3Enantiomeric impurities
Track 18-4Organic volatile impurities
Track 18-5Signal impurities
Track 19:Absorption, Distribution, Metabolism and Elimination
Track 19-1Bio availability of drug based on drug efficacy
Track 19-2Non-alcoholic fatty liver disease (NAFLD)
Track 19-3Genome-wide mRNA levels in samples
Track 19-4Role of pharmaceutical analysis in ADME
Track 20:Assay Methods Based on Separation Techniques
Track 20-1Liquid-liqid extraction
Track 20-2Thin layer chromatography
Track 20-3Gas liquid chromatography
Track 20-4Size exclusion chromatography
Track 20-5Distribution co-efficient
全部留言
重要日期
-
会议日期
10月02日
2017
至10月03日
2017
-
10月03日 2017
注册截止日期
留言